1
SCHEDULE 13D Page 1 of 9
SEC POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION
1746 CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM
(2-98) DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER.
==========================
OMB APPROVAL
==========================
OMB Number: 3235-0145
--------------------------
Expires: October 31, 2002
--------------------------
Estimated average burden
hours per response... 14.9
==========================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)*
Moore Medical Corp.
(Name of Issuer)
Common Stock, $.01 Par Value
(Title of Class of Securities)
615799103
(CUSIP Number)
David Selangut, ESQ. c/o 370 Lexington Avenue, New York, NY 10017
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
May 18, 2001
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(F) or 240.13d-1(g),
check the following box. [ ]
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
2
SCHEDULE 13D
CUSIP NO. 615799103 PAGE 2 OF 9
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS (ENTITIES ONLY)
Bruce J. Haber
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
X (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
PF
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) / /
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 60,750
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 12,500
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
60,750
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
12,500
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
73,250
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) / /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.31%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
IN
--------------------------------------------------------------------------------
3
SCHEDULE 13D
CUSIP NO. 615799103 PAGE 2 OF 9
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS (ENTITIES ONLY)
Royce Kanofsky
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
X (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
PF
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) / /
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 71,650
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 500
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
71,650
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
500
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
72,150
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) / /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.27%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
IN
--------------------------------------------------------------------------------
4
SCHEDULE 13D
CUSIP NO. 615799103 PAGE 2 OF 9
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS (ENTITIES ONLY)
Louis Buther
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
X (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
PF
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) / /
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 12,800
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
12,800
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12,800
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) / /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.41%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
IN
--------------------------------------------------------------------------------
5
SCHEDULE 13D
CUSIP NO. 615799103 PAGE 2 OF 9
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS (ENTITIES ONLY)
FHS Enterprises LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
X (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) / /
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 500
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
500
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
500
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) / /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.02%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
CO
--------------------------------------------------------------------------------
6
Item 1 Security and Issuer
1) Common Stock, $0.01 par value (the "Shares")
Moore Medical Corp. (the "Issuer")
P.O. Box 1500
389 John Downey Drive
New Britain, CT 06050
Item 2 Identity and Background
1.a) Bruce J. Haber
b) 65 The Oaks
Roslyn, NY 11576
c) President, CEO, Director of MedConduit.com
d-e) There has been no convictions, proceedings or securities
violations in the past 5 years.
f) U.S. Citizen
2.a) Royce Kanofsky
b) 1665 Warwick Road
Hewlett, NY 11557
c) Investment Banking
d-e) There has been no convictions, proceedings or securities
violations in the past 5 years.
f) U.S. Citizen
3.a) Louis Buther
b) 205 Ridgefield Avenue
South Salem, N.Y. 10590
c) Consultant
d-e) There has been no convictions, proceedings or securities
violations in the past 5 years.
f) U.S. Citizen
4.a) FHS Enterprises LLC ("FHS")
b) 145 Huguenot Street, Suite 402
New Rochelle, NY 10801
Mr. Haber and Mr. Kanofsky are both members of FHS.
c) FHS Enterprises LLC was organized to acquire and hold
securities.
d-e) N/A
7
f) FHS Enterprises LLC is a New York Limited Liability Company
organized on February 21, 2001
The aforementioned parties together will be referred to as the
"Reporting Parties."
Item 3 Source and Amount of Funds or Other Consideration
1. The shares of common stock were purchased with personal funds
of the Reporting Parties.
Item 4 Purpose of Transaction
The Reporting Parties acquired and continue to hold the Shares for
investment purposes. They would like to assist the Issuer in identifying new
strategies to enhance shareholder value and maximize investments in both its
core business and e-commerce. The Reporting Party intends to seek removal of the
Company's "Poison Pill" and has requested that the Board of the Company make
sure Management incentives are aligned with creating shareholder value and
preserving the shareholders' portion of the Company's enterprise value. Each of
the Reporting Parties intends to review his or its investment in the Issuer on a
continuing basis and, depending on market conditions, the Issuer's business and
financial condition, and other material factors, each of the Reporting Parties
may purchase additional shares of Common Stock or sell some or all of their
holdings in a public or private transaction.
The Reporting Parties have no present plans or proposals that relate to
or that would result in any of the actions specified in clauses (a)-(j) of Item
4 of Schedule 13D of the Act.
Item 5 Interest in Securities of the Issuer
The Reporting Parties Hereby amend Item 5 as follow:
1. Bruce J. Haber
a-b) Mr. Bruce J. Haber may be deemed to beneficially own
73,250 shares of the Common Stock, which constitutes
approximately 2.31% of the outstanding shares of
Common Stock (based on the 3,153,943 shares of Common
Stock outstanding as of April 27, 2001 as reported on
the Quarterly Report on Form 10-Q filed by the
Company on March 31, 2001). Of these shares:
i) 55,750 shares of Common Stock are owned
directly by Mr. Haber.
ii) 12,000 shares are owned by his wife, Mr.
Haber disclaims beneficial ownership of the
shares held by his wife.
8
iii) 5,000 shares are own by his daughter in a
custodian account in which Mr. Haber is the
custodian.
iv) 500 shares are attributed to Mr. Haber by
virtue of his part ownership of FHS.
c) Mr. Bruce J. Haber purchased 800 shares on May 18,
2001.
Mr. Haber, Mr. Kanofsky, Mr. Buther and FHS, as a group beneficially
own 5.01% of the Company's shares of Common Stock.
2. Royce Kanofsky
a-b) Mr. Royce Kanofsky beneficially owns 72,150 shares of
the Common Stock, which constitutes approximately
2.27% of the outstanding shares of Common Stock. Of
these shares, 71,650 are owned directly by Mr.
Kanofsky and 500 shares are attributed to him by
virtue of his part ownership of FHS.
c) Mr. Royce Kanofsky purchased 800 shares on May 18,
2001.
Mr. Haber, Mr. Kanofsky, Mr. Buther and FHS, as a group beneficially
own 5.01% of the Company's shares of Common Stock.
3. Louis Buther
a-b) Mr. Louis Buther beneficially owns 12,800 shares of
the Common Stock, which constitutes approximately
0.41% of the outstanding shares of Common Stock.
Mr. Haber, Mr. Kanofsky, Mr. Buther and FHS, as a group beneficially
own 5.01% of the Company's shares of Common Stock.
4. FHS
a-b) FHS beneficially owns 500 shares of the Common Stock,
which constitutes approximately 0.02% of the
outstanding shares of Common Stock.
Mr. Haber, Mr. Kanofsky, Mr. Buther and FHS, as a group beneficially
own 5.01% of the Company's shares of Common Stock.
Item 6 Contracts, Arrangements, Understandings or Relationships With
Respect to the Securities of the Issuer
NONE
9
Item 7 Material Exhibits to be filed
EXHIBIT A - A letter from Bruce J. Haber of FHS Enterprises,
LLC to Moore Medical Corp. dated May 4, 2001.
After reasonable inquiry and to the best of our knowledge and belief,
we certify that the information set forth in this statement is true, complete
and correct.
Date: May 21, 2001
FHS Enterprises LLC
By: /s/ Bruce J. Haber
------------------
Bruce J. Haber
President
/s/ Bruce J. Haber
------------------
Bruce J. Haber
/s/ Royce Kanofsky
------------------
Royce Kanofsky
/s/ Louis Buther
----------------
Louis Buther